Propionic Acid

Propionic Acid

SCHEMBL4153857

CCC(=O)O.O=c1[nH]c2ccc(NS(=O)(=O)c3ccc(Cl)s3)cc2c2cc[nH]c12

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 4/20 0.45
ALDH1A1 P00352 4/20 0.45
LMNA P02545 3/20 0.45
GALR3 O60755 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.43
BRD4 O60885 8/20 0.42
KIT P10721 1/20 0.42
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4169462 0.85 BRD4 (0.61) MEN1KMT2AMAPTALDH1A1LMNA
Propionic Acid SCHEMBL4169897 0.85 BRD4 (0.59) HTR6GAAMAPTBRD4
Propionic Acid SCHEMBL4176366 0.84 BRD4 (0.63) HTR6MEN1KMT2AMAPTALDH1A1
Propionic Acid SCHEMBL4158106 0.84 BRD4 (0.60) HTR6BRD4
Propionic Acid SCHEMBL4159609 0.83 BRD4 (0.45) BRD4
Propionic Acid SCHEMBL4157723 0.83 BRD4 (0.62) HTR6KMT2AALDH1A1BRD4
Propionic Acid SCHEMBL4155591 0.82 BRD4 (0.50) HTR6MEN1KMT2AMAPTALDH1A1
Propionic Acid SCHEMBL4155599 0.81 BRD4 (0.49) HTR6MEN1KMT2AGAABRD4
Propionic Acid SCHEMBL4159957 0.81 BRD4 (0.49) HTR6MEN1KMT2ABRD4
Propionic Acid SCHEMBL4160232 0.81 BRD4 (0.51) GAAMAPTLMNABRD4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 HTR6 4018/4885MEN1 3749/4885KMT2A 1882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.